Galanin peptide stimulates fatty acid β‐oxidation in the liver and lipolysis in adipose tissue, indicating that the anti‐obesity effect of galanin peptide may stem from anorexigenic actions and improvement of lipid metabolism in peripheral tissues via the sympathetic nervous system [96]. This evidence concerns the gene GAL and obesity due to melanocortin 4 receptor deficiency.